-

Thermo Fisher Scientific Releases 2022 Corporate Social Responsibility Report

Company highlights colleagues’ commitment to innovation, progress toward ambitious targets, and building a brighter future for all stakeholders

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today released its annual Corporate Social Responsibility (CSR) report. The report highlights the company’s commitment to society and stakeholders and provides insight into its CSR progress and environmental, social and governance (ESG) efforts.

“Our Mission to enable our customers to make the world healthier, cleaner and safer inspires our 125,000 colleagues every day. We are proud of the progress we are making across our CSR commitments and ESG priorities and we’re excited about the opportunities ahead to continue making a positive impact.”

Thermo Fisher’s CSR report centers on four key pillars—Environment, Colleagues, Communities, and Operations—aligned to the company’s strategy and values; and showcases the innovation made possible by the passion and talent of its more than 125,000 colleagues worldwide. Highlights of the report include:

Environment

  • Progressed the company’s net-zero emissions goals—approved by the Science Based Targets initiative (SBTi)—for Scopes 1, 2 and 3; achieving a 25% reduction in Scopes 1 and 2 compared to 2018; reaching fossil fuel-free status at 20 sites; and powering 150 sites with renewable electricity.
  • Expanded its Design for Sustainability program to accelerate the integration of environmental considerations in product innovation, furthering a long-standing colleague-driven commitment to deliver new solutions that help customers reach their business and sustainability goals.
  • Delivered on the company’s commitment to climate and nature by introducing near-term targets aimed at addressing water scarcity and reducing waste.

Colleagues

  • Increased global representation of women in the company’s workforce by 5.9% since 2019, including a 9.3% increase of U.S. women in executive management roles.
  • Provided additional support to meet colleagues’ evolving needs, including making special payments to offset the global impact of inflation, and expanding mental health coverage in the U.S. by implementing a Behavioral Health Navigator platform.

Communities

  • Reached more than 89,500 students through global programming to advance STEM education access and equity, completed a record number of community engagement events resulting in over 120,000 colleague volunteer hours, and launched the Thermo Fisher Scientific Junior Innovators Challenge, the premier middle school STEM competition in the U.S.
  • Advanced global health equity in more than 100 low- and middle-income countries and developed public-private partnerships to save more lives by making a positive impact in the management of infectious diseases like HIV/AIDS.

Operations

  • Optimized the company’s responsible sourcing program to increase value to customers, assessing 50% of its direct materials supply for ESG performance and granting over $2 billion in awards to small and diverse suppliers.

In reporting its CSR progress, the company considers internationally recognized standards, guidelines and reference frameworks including the Global Reporting Initiative (GRI) Standards, the IFRS Foundation’s SASB Standards, the Task Force on Climate-related Financial Disclosures (TCFD), and the United Nations Sustainable Development Goals (SDGs). The company makes additional topic-specific ESG data available to key stakeholders through CDP, EcoVadis and the voluntary disclosure of its annual EEO-1 information.

Learn more at www.thermofisher.com/csr.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media:
Sandy Pound
Thermo Fisher Scientific
Phone: 781-622-1223
E-mail: sandy.pound@thermofisher.com

Investor:
Rafael Tejada
Thermo Fisher Scientific
Phone: 781-622-1356
E-mail: rafael.tejada@thermofisher.com

Thermo Fisher Scientific Inc.

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media:
Sandy Pound
Thermo Fisher Scientific
Phone: 781-622-1223
E-mail: sandy.pound@thermofisher.com

Investor:
Rafael Tejada
Thermo Fisher Scientific
Phone: 781-622-1356
E-mail: rafael.tejada@thermofisher.com

More News From Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers for Isotope Ratio Analysis, Enabling More Labs to Decode the Story Behind a Sample

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today introduced the Thermo Scientific™ Orbitrap™ Isora™ Mass Spectrometer and Orbitrap Isora Pro Mass Spectrometer, the company’s first Orbitrap instruments with a dedicated isotope ratio analysis mode. Together with the Thermo Scientific™ Vanquish™ Duo UHPLC System and new Isotope Discoverer™ Software, the instruments form an integrated workflow designed to make molecular-level isotope ratio analys...

Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing....

Thermo Fisher Scientific Collaborates with The Michael J. Fox Foundation to Advance Proteomics-Enabled Parkinson’s Precision Medicine

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the completion of Olink Explore HT proteomic analysis of approximately 5,500 research samples from The Michael J. Fox Foundation’s (MJFF) landmark study, the Parkinson’s Precision Medicine Initiative (PPMI). The resulting data are now in PPMI’s data repository, where they are available to the global research community. The project creates a large-scale proteomics resource designe...
Back to Newsroom